SS
CRBU icon

SBI Securities’s Caribou Biosciences CRBU Stock Holding History

SBI Securities’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139 Sell
79
-13
-14% -$26 ﹤0.01% 3426
2026
Q1 		$175 Hold
92
– – ﹤0.01% 3269
2025
Q4 		$146 Sell
92
-66
-42% -$139 ﹤0.01% 3300
2025
Q3 		$368 Sell
158
-503
-76% -$950 ﹤0.01% 3099
2025
Q2 		$833 Buy
661
+507
+329% +$499 ﹤0.01% 2761
2025
Q1 		$141 Buy
154
+2
+1% +$3 ﹤0.01% 3330
2024
Q4 		$242 Buy
+152
New +$306 ﹤0.01% 3173

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SBI Securities's CRBU Position: Q2 2026 in Review

SBI Securities reduced its Caribou Biosciences (CRBU) stake by 14% in Q2 2026, selling an estimated $26 and leaving 79 shares worth $139. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

SBI Securities first reported a position in CRBU in Q4 2024 and has held it in 7 quarters since. The position peaked at $833 in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • SBI Securities held 79 shares of Caribou Biosciences worth $139 as of Q2 2026.
  • SBI Securities sold 13 Caribou Biosciences shares in Q2 2026, an estimated $26.
  • Caribou Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3426 holding.
  • SBI Securities first reported a position in Caribou Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Caribou Biosciences position peaked at $833 in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.